UGG outlet online Characteristics of middle-aged female obese patients exercise prescription and to develop methods Cases. The two sets of data through without statistical difference (P> 0.05), are comparable. 1.2 treatment in both groups given antibiotics, antispasmodic, cough, asthma and other symptomatic treatment, the treatment of aerosol inhalation. Control group 2 40 000 U of gentamicin, chymotrypsin 2.5 to 5mg, per 0.1 ~ 0.2mg/kg of dexamethasone, 2 times / d, plus 20mL saline, each inhalation time of 20 minutes; observation group in addition to gentamicin, chymotrypsin, dexamethasone, plus ribavirin 15mg / (kg · d), sub-2 plus normal saline inhalation time the same as the control group. Both groups use the production of a plant of Anshan City, Liaoning Radio JWC 2 Series ultrasonic nebulizer, aerosol inhalation, treatment 5 to 7 days, during treatment with dexamethasone can stop or reduce in accordance with the specific circumstances of the children. 1.3 Clinical observation mainly observed after treatment in children with clinical symptoms, signs, x-ray changes and hospitalization days. Judgment index as follows: ① The fever subsided; ② The wheezing j14 loss of time; (3) cough disappeared time; ④ The the lungs 哕 sound? 14 lost time; ⑤ The the x-ray recovery time; ⑥ The number of days in the hospital. T test. 2 results by ribavirin aerosol inhalation treatment, 60 cases of infants and young children in the observation group, 49 cases of fever subsided time average (3.8 ± 1.2) days, wheezing disappearance time average (3.8- t-1.1) days, the cough disappeared average (6.8 ± 2.1) days, lung 哕 tone i14 lost an average of (6.1 ± 1.8) days, the X-ray normalization The average time (8.1 ± 2.4) days, and the average length of stay (9.8 ± 1.9) days; 6O patients in the control group of 48 cases of fever subsided time average (4.5 ± 1.3.) days, the average the wheezing disappearance time (4.9 ± 1.4) days, the cough disappeared average (7.5 ± 1.8) days, the lungs 哕 sounds disappear an average of (6.8 ± 1 0.6) days, the average x-ray normalization (9.0 ± 2.3) days, the average length of stay (10.6 ± 2.1) days. The statistical treatment, the efficacy of the observation group was significantly higher (P <0.01 or P <0.05). Results are shown in Table 1. Table 1 observation group and control group after treatment symptoms, signs, x-ray changes, and the average length of hospital stay (d, the x ± S) to discuss bronchiolitis found only in the 2 years of age infants, especially 1 to 6 months more common in infants and young children, the incidence and anatomical characteristics of the age of the infant bronchial inflammation, often involving the alveolar, interstitial lung alveolar wall, by a viral infection caused by respiratory syncytial virus is the most common. For broad-spectrum antiviral ribavirin, was inhibited by a variety of RNA and DNA virus, respiratory syncytial virus, influenza virus, parainfluenza virus, measles virus can be effectively inhibited j. Ribavirin administration of oral, intravenous, atomization of three kinds. For infants, oral administration is more difficult and prone to choking; intravenous administration of pain and side effects; aerosol inhalation artificially preferred. Ultrasonic aerosol inhalation treatment liquid in the ultrasonic nebulizer, the electric coupling shock, the liquid bottom of the film, ultrasonic liquid bottle of water-soluble drugs, so that the liquid atomization for The diameter of the particles of about 5m, by the mouth, nose suction trachea, bronchus, and reach the alveoli and rapidly absorbed, direct effect on target organs play a therapeutic role. Wet respiratory tract, secretions discharged aerosol inhalation, and atomization line topical inhaled into the blood circulation medicine less and avoid liver first pass effect easy to use, is a convenient and effective delivery methods for infants with respiratory infections. Application of ribavirin aerosol inhalation rule of man boil with bronchiolitis, and achieved good effect, significant difference compared with the control group (P <0.01 or P <0.05), indicating that ribavirin aerosol inhalation treatment of capillary bronchitis has a direct, efficient, economical, fast and convenient medication, side effects of small features, worthy of wide application.